rug makers in the United Kingdom have gone to court in hopes of preventing the country’s National Health Service from imposing pricing limits on medicines.

The Association of British Pharmaceutical Industry is responding to a move by the government to limit funding for any prescription drug that will cost the NHS more than roughly $25 million in any of the first three years of use.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • One might observe that the industry seems to hold the position that just because you can’t afford to pay for something is no excuse for not buying it. Another example of where ‘kitchen table finances’ don’t apply – or some don’t want them to apply – to national issues. To quote our scribe ‘concerns persist that some drugs may not be covered in the future due to strained finances.’
    If there are such problems, then lower the price$ … oh, wait, I’m spouting heresy again. My apologies!

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.